|
Volumn 74, Issue 1, 2001, Pages 95-100
|
Lethal adenovirus infection in a patient who had undergone nonmyeloablative stem cell transplantation
|
Author keywords
Adenovirus; Nonmyeloablative regimen; Virus immunity
|
Indexed keywords
BUSULFAN;
DRUG DERIVATIVE;
FLUDARABINE;
IMMUNOSUPPRESSIVE AGENT;
LYMPHOCYTE ANTIBODY;
METHYLPREDNISOLONE;
TACROLIMUS;
VIDARABINE;
ALLOTRANSPLANTATION;
ARTICLE;
CASE REPORT;
CYSTITIS;
FATALITY;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
HUMAN ADENOVIRUS;
IMMUNE DEFICIENCY;
IMMUNOSUPPRESSIVE TREATMENT;
ISOLATION AND PURIFICATION;
LUNG LAVAGE;
LYMPHOCYTE COUNT;
LYMPHOCYTE SUBPOPULATION;
MALE;
MIDDLE AGED;
MYELOID LEUKEMIA;
T LYMPHOCYTE;
VIROLOGY;
VIRUS INFECTION;
VIRUS PNEUMONIA;
ADENOVIRIDAE INFECTIONS;
ADENOVIRUSES, HUMAN;
ANTILYMPHOCYTE SERUM;
BRONCHOALVEOLAR LAVAGE FLUID;
BUSULFAN;
CYSTITIS;
FATAL OUTCOME;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
IMMUNOCOMPROMISED HOST;
IMMUNOSUPPRESSIVE AGENTS;
LEUKEMIA, MYELOID, CHRONIC-PHASE;
LYMPHOCYTE COUNT;
LYMPHOCYTE SUBSETS;
MALE;
METHYLPREDNISOLONE;
MIDDLE AGED;
PNEUMONIA, VIRAL;
T-LYMPHOCYTES;
TACROLIMUS;
TRANSPLANTATION CONDITIONING;
TRANSPLANTATION, HOMOLOGOUS;
VIDARABINE;
|
EID: 0035407403
PISSN: 09255710
EISSN: None
Source Type: Journal
DOI: 10.1007/BF02982557 Document Type: Article |
Times cited : (9)
|
References (2)
|